Ali Kashif, a recent immigrant, is admitted for continued treatment of CHF. During the assessment, he reveals that he has been u
sing drugs containing amrinone because he did not respond positively to treatment with digoxin, diuretics, and vasodilators. Is there a cause for concern in this case?
Answer: No, there is no cause for concern because amrinone is the same as Inocor
Explanation:
The trade name for amrinone is inocor which helps improve the prognosis in patients with congestive heart failure (CHF)
Digoxin is used to maintain clinical stability and improve symptoms, quality of life and exercise tolerance in patients with congestive heart failure.
Since he did not respond to treatment with digoxin, diuretics and vasodilators and has decided to take amrinone then there is no cause for alarm since amrinone is the same as inocor
